These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Botulinum toxin injection for chronic pelvic pain: A systematic review. Luo FY; Nasr-Esfahani M; Jarrell J; Robert M Acta Obstet Gynecol Scand; 2020 Dec; 99(12):1595-1602. PubMed ID: 32597494 [TBL] [Abstract][Full Text] [Related]
23. FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia. Spiegel LL; Ostrem JL; Bledsoe IO Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32429600 [TBL] [Abstract][Full Text] [Related]
24. The role of botulinum toxin in management of pain: an evidence-based review. Qerama E; Fuglsang-Frederiksen A; Jensen TS Curr Opin Anaesthesiol; 2010 Oct; 23(5):602-10. PubMed ID: 20585245 [TBL] [Abstract][Full Text] [Related]
25. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review. Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915 [TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin treatment of temporomandibular joint pain in patients with bruxism: A prospective and randomized clinical study. Kaya DI; Ataoglu H Niger J Clin Pract; 2021 Mar; 24(3):412-417. PubMed ID: 33723117 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of spasticity with injections of botulinum toxin. Review of the literature]. Fève A; Decq P; Filipetti P; Kéravel Y Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435 [TBL] [Abstract][Full Text] [Related]
28. Safety and pharmacodynamics of a novel recombinant botulinum toxin E (rBoNT-E): Results of a phase 1 study in healthy male subjects compared with abobotulinumtoxinA (Dysport®). Pons L; Vilain C; Volteau M; Picaut P J Neurol Sci; 2019 Dec; 407():116516. PubMed ID: 31655410 [TBL] [Abstract][Full Text] [Related]
29. Pneumatic dilation and botulinum toxin: when and why? Bozzi R; Di Martino V; Inzirillo A; D'Avenia E; Inzirillo M; Cattaneo F; Cattaneo D Ann Ital Chir; 2013; 84(5):501-4. PubMed ID: 24141252 [TBL] [Abstract][Full Text] [Related]
30. Introduction to the Toxins Special Issue on Botulinum Neurotoxins in the Nervous System: Future Challenges for Novel Indications. Luvisetto S Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32957443 [No Abstract] [Full Text] [Related]
31. Use of botulinum toxin in Parkinson's disease. Jocson A; Lew M Parkinsonism Relat Disord; 2019 Feb; 59():57-64. PubMed ID: 30579818 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin A in the treatment of myofascial pain and dysfunction: the case against its use. Laskin DM J Oral Maxillofac Surg; 2012 May; 70(5):1240-2. PubMed ID: 22538023 [No Abstract] [Full Text] [Related]
34. Botulinum toxin injection into the lacrimal gland for treatment of proximal nasolacrimal duct obstructions in children. Eustis HS; Babiuch A J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e75-7. PubMed ID: 25427340 [TBL] [Abstract][Full Text] [Related]
35. The Botulinum Toxin as a Therapeutic Agent: Molecular Structure and Mechanism of Action in Motor and Sensory Systems. Kumar R; Dhaliwal HP; Kukreja RV; Singh BR Semin Neurol; 2016 Feb; 36(1):10-9. PubMed ID: 26866491 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review. Mitchell SD; Sidiropoulos C Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808714 [TBL] [Abstract][Full Text] [Related]